DocuSign, Inc. (NASDAQ:DOCU - Get Free Report) Director Teresa Briggs sold 534 shares of the firm's stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $94.60, for a total value of $50,516.40. Following the transaction, the director now directly owns 7,736 shares of the company's stock, valued at approximately $731,825.60. This trade represents a 6.46 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
DocuSign Stock Up 0.3 %
Shares of DocuSign stock traded up $0.34 during trading hours on Tuesday, reaching $98.17. 3,797,399 shares of the stock traded hands, compared to its average volume of 2,996,714. DocuSign, Inc. has a one year low of $48.70 and a one year high of $107.86. The firm has a market capitalization of $19.83 billion, a price-to-earnings ratio of 20.24, a P/E/G ratio of 8.72 and a beta of 0.92. The company has a 50 day moving average price of $79.37 and a 200 day moving average price of $64.02.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently commented on the company. Wells Fargo & Company increased their target price on DocuSign from $50.00 to $70.00 and gave the stock an "underweight" rating in a research note on Friday, December 6th. Piper Sandler raised their price objective on shares of DocuSign from $60.00 to $90.00 and gave the company a "neutral" rating in a research note on Friday, December 6th. Robert W. Baird upped their target price on shares of DocuSign from $59.00 to $100.00 and gave the stock a "neutral" rating in a research note on Friday, December 6th. Royal Bank of Canada reissued a "sector perform" rating and set a $90.00 price target (up previously from $57.00) on shares of DocuSign in a research report on Friday, December 6th. Finally, JPMorgan Chase & Co. upped their price objective on DocuSign from $50.00 to $70.00 and gave the company an "underweight" rating in a research report on Tuesday, December 3rd. Three equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $92.45.
View Our Latest Analysis on DOCU
Institutional Trading of DocuSign
Several large investors have recently added to or reduced their stakes in DOCU. Garden State Investment Advisory Services LLC purchased a new position in shares of DocuSign during the 3rd quarter worth $210,000. Franklin Resources Inc. raised its holdings in DocuSign by 12.1% in the 3rd quarter. Franklin Resources Inc. now owns 520,925 shares of the company's stock worth $35,870,000 after purchasing an additional 56,221 shares during the period. Tidal Investments LLC lifted its position in DocuSign by 62.8% during the third quarter. Tidal Investments LLC now owns 44,946 shares of the company's stock valued at $2,791,000 after purchasing an additional 17,339 shares in the last quarter. Optimist Retirement Group LLC grew its holdings in DocuSign by 3.8% during the third quarter. Optimist Retirement Group LLC now owns 4,416 shares of the company's stock valued at $274,000 after purchasing an additional 161 shares during the period. Finally, Wilmington Savings Fund Society FSB purchased a new stake in DocuSign in the third quarter worth about $51,000. 77.64% of the stock is currently owned by institutional investors.
About DocuSign
(
Get Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider DocuSign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.
While DocuSign currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.